TITLE

PLATELET ACTIVATION DISTRIBUTION IN CHINESE HIGH RISK PATIENTS WITH ACUTE CORONARY SYNDROME

PUB. DATE
October 2010
SOURCE
Heart;Oct2010 Supplement, pA100
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Platelet Activation Distribution in Chinese High Risk Patients With Acute Coronary Syndrome" by Ren Yihong and colleagues is presented.
ACCESSION #
66245716

 

Related Articles

  • Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes. Tricoci, Pierluigi; Huang, Zhen; Held, Claes; Moliterno, David J.; Armstrong, Paul W.; Van de Werf, Frans; White, Harvey D.; Aylward, Philip E.; Wallentin, Lars; Chen, Edmond; Lokhnygina, Yuliya; Pei, Jinglan; Leonardi, Sergio; Rorick, Tyrus L.; Kilian, Ann M.; Jennings, Lisa H.K.; Ambrosio, Giuseppe; Bode, Christoph; Cequier, Angel; Cornel, Jan H. // New England Journal of Medicine;1/5/2012, Vol. 366 Issue 1, p20 

    Background: Vorapaxar is a new oral protease-activated�receptor 1 (PAR-1) antagonist that inhibits thrombin-induced platelet activation. Methods: In this multinational, double-blind, randomized trial, we compared vorapaxar with placebo in 12,944 patients who had acute coronary syndromes...

  • Mean platelet volume in ST elevation and non-ST elevation myocardial infarction. Ulusoy, Rifat Eralp; Yokuşoğlu, Mehmet; Kırılmaz, Ata; Nevruz, Oral; Baysan, Oben; Kılıçaslan, Fethi; Cebeci, Bekir Sıtkı // Gulhane Medical Journal;Jun2011, Vol. 53 Issue 2, p114 

    Platelet activation is thought to play a key pathogenetic mechanism in acute coronary syndromes. We investigated the mean platelet volume and platelet count in patients with both ST elevation myocardial infarction and non-ST elevation myocardial infarction. Fifty two patients with non-ST...

  • Current antiplatelet options for NSTE-ACS patients. Cayla, G.; Silvain, J.; O’Connor, S.A.; Collet, J.-P.; Montalescot, G. // QJM: An International Journal of Medicine;Oct2012, Vol. 105 Issue 10, p935 

    Non-ST elevation (NSTE) myocardial infarction and unstable angina are the most common clinical presentations of acute coronary syndrome (ACS). Platelet activation is central to the pathogenesis of NSTE-ACS and consensus guidelines that advocate early revascularization supported by intensive...

  • Proteins Involved in Platelet Signaling Are Differentially Regulated in Acute Coronary Syndrome: A Proteomic Study. Parguiña, Andrés Fernández; Grigorian-Shamajian, Lilian; Rosa M. Agra; Teijeira-Fernández, Elvis; Rosa, Isaac; Alonso, Jana; Viñuela-Roldán, Juan E.; Seoane, Ana; Gonzá lez-Juanatey, JoséRamón; García, Ángel // PLoS ONE;2010, Vol. 5 Issue 10, p1 

    Background: Platelets play a fundamental role in pathological events underlying acute coronary syndrome (ACS). Because platelets do not have a nucleus, proteomics constitutes an optimal approach to follow platelet molecular events associated with the onset of the acute episode....

  • An insight into the Interaction between Clopidogrel and Proton Pump Inhibitors. Shah, Bhavik S.; Parmar, Sanjay A.; Mahajan, Shailaja; Mehta, Anita A. // Current Drug Metabolism;Feb2012, Vol. 13 Issue 2, p225 

    Platelet activation and aggregation have been established as pivotal elements in the pathogenesis of atherosclerotic and ischemic diseases, including acute coronary syndromes. The difficulty of achieving optimal platelet inhibition remains a major constraint following dual-antiplatelet therapy,...

  • Prognostic Value of Mean Platelet Volume in Patients With Non-ST-Elevation Acute Coronary Syndrome. López-Cuenca, Angel A.; Tello-Montoliu, Antonio; Roldán, Vanessa; Pérez-Berbel, Patricio; Valdés, Mariano; Marín, Francisco // Angiology;Aug2012, Vol. 63 Issue 6, p241 

    The aim of this study is to determine mean platelet volume (MPV) in a population with non-ST-elevation acute coronary syndrome (nSTEACS) and explore its relation with prognosis. Patients (n = 329) with a diagnosis of nSTEACS at admission were recruited, with a determination of MPV in the first...

  • Clopidogrel.  // Reactions Weekly;2/4/2012, Issue 1387, p14 

    The article describes the case of an 84-year-old man with acute coronary syndrome who developed neutropenia while being treated with clopidogrel.

  • Vincristine.  // Reactions Weekly;10/6/2012, Issue 1422, p49 

    The article describes the case of a woman who developed acute coronary syndrome with complete atrioventricular block after receiving vincristine for multiple myeloma.

  • Fluorouracil.  // Reactions Weekly;9/29/2012, Issue 1421, p26 

    The article describes the case of a 55-year-old man who developed acute coronary syndrome with coronary thrombosis while receiving fluorouracil for the treatment of gastric cancer.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics